Where does Emplase Medical Technologies, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Emplase Medical Technologies, LLC ranks #35,183 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Emplase Medical Technologies, LLC hold?

Emplase Medical Technologies, LLC holds 7 US utility patents granted between 2024 and 2025, spanning 3 technology areas.

What is Emplase Medical Technologies, LLC's Innovation Score?

Emplase Medical Technologies, LLC has an Innovation Score of 45.5 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Emplase Medical Technologies, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Emplase Medical Technologies, LLC.

What does claim depth mean for Emplase Medical Technologies, LLC's patents?

Emplase Medical Technologies, LLC's patents average 20.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Emplase Medical Technologies, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Emplase Medical Technologies, LLC

Q: What technology areas does Emplase Medical Technologies, LLC focus on?

Emplase Medical Technologies, LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 7 patents, ranking #891 of 3,082 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Emplase ranks #35,183 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#35,183
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.5/100): 20.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R35183 · US Corporation #35,183 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #35,183/49,997
PHOTO-FINISH Emisense
CPC-NARROW A61F · 3 areas
INNOV-PAR 45.5/100
CLAIMS-DENSE 20.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Emisense Technologies, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Emplase’s 45.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (16%) Velocity 20.0 pts (44%) Breadth 6.1 pts (13%) Claim depth 12.2 pts (27%)

Qualcomm Incorporated · highest

85
Emplase Medical · this assignee

45
3D Lighting… · lowest

7

What this shows Emplase's Innovation Score is 45.5/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Emplase?

Each dot is one of Emplase’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Emplase’s own 20.3 claims/patent is ABOVE the 15.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Emplase vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Emplase's grants concentrate

Emplase Medical Technologies, LLC is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). By volume, Emplase sits between Emisense Technologies, LLC and Endostream Medical Ltd..

Emplase's three-year grant acceleration

Emplase Medical Technologies, LLC shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Emisense

7
Emmeci S P A

7
Emonster

7
EMP IP Holding

7
Emplicure AB

7
Emza Visual Sense

7
Endocontrol

7
Endostream Medical

7
Emplase Medical ◀

7

What this shows Emplase holds 7 patents at rank #35,140, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Emplase

By rank, the assignees closest to #35,140 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Emplase's primary technology class.

Emplase's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

Emplase Medical Technologies, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	3	42.9%
2025partial year	4	57.1%

Which technologies does Emplase Medical Technologies, LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 7

A61B - DIAGNOSIS; SURGERY; Identification 7

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 6

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Emplase Medical Technologies, LLC's patent record in context - here's where to go next.

Emplase Medical Technologies, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #35,183 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Emplase Medical Technologies, LLC against Emisense Technologies, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.